Policy Statement – Streamlining and reform of Study Set-Up
Date: 25 April 2025
Latest figures in the UK Clinical Research Delivery Performance Indicators Report (UK KPI) suggest most commercial studies still face delays in setting up once regulatory approvals are obtained. All four UK nations are fully committed to working with partners across the clinical delivery system via a newly recharged UK Clinical Research Delivery (UKCRD) programme to make the UK a world leader in clinical research and streamlining and reforming the set-up and delivery of clinical trials is a key priority for the programme. Please see link below for a Policy Statement Published 2nd April 2025.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok